TRACK SHIPMENTS
|
View Worldwide Contacts

Category Archives: Cellular-Therapy

Cellular Immunotherapy Logistics

[White Paper] Transforming the Cellular Immunotherapy Supply Chain

By | Cellular-Therapy, Uncategorized | No Comments

Learn how Cardinal Health and MNX Global Logistics collaborate to strengthen the cellular immunotherapy supply chain and help you commercialize your therapies Nicole’s story. It was her only chance to live. Nicole had already endured seven rounds of chemotherapy, but she was losing her fight with leukemia. The damage to her cells was taking its toll. Then an emerging immunotherapy…

Read More
Delta A350

MNX and Delta Cargo Conduct Healthcare and Life Sciences Shipment Roadshow at JFK International Airport

By | Cellular-Therapy, Life Sciences, Organ for Transplant, Radiopharmaceutical | No Comments

MNX in collaboration with Delta Cargo recently conducted a healthcare and life sciences roadshow with Delta’s ramp and cargo handling agents at JFK International Airport. Both companies got together to share best practices and to develop operational procedures to improve the handling of life-saving healthcare shipments that move to, from or through the JFK hub. The theme of the roadshow…

Read More
CAR-T Commercialization Logistics

Revolutionizing Logistics for CAR-T Therapy Commercialization

By | Cellular-Therapy, Life Sciences | No Comments

When it comes to CAR-T Therapy commercialization, you need to think BEYOND THE BOX. Unlike during a trial where patients are limited to treatment centers in select geographies, CAR-T therapy commercialization will bring about new challenges in the logistics management process. Here at MNX, we never forget that your shipments are more than just boxes. We know that what we…

Read More
Cell-Therapy Logistics

FDA Approval of First Cellular-Therapy Treatment for Cancer Underscores the Importance of a Robust Logistics and Transportation Process

By | Cellular-Therapy, Life Sciences | No Comments

The food and drug administration today approves the first cellular-therapy treatment for acute lymphoblastic leukemia, a form of blood and bone marrow cancer most commonly found in children. According to NPR: “The treatment, which is also called CTL109, produced remission within three months in 83 percent of 63 pediatric and young adult patients. The patients had failed to respond to standard…

Read More